Latest news from Datamonitor

June 10, 2008
Sales and Marketing

Pharmacovigilance solutions: essential for the future of healthcareAlthough many newer pharmacovigilance solutions are still in the nascent stages, and despite …

Think tank questions polyclinic plans

June 6, 2008

A government strategy to transform primary care in England has been dealt a blow by a respected think tank, which …

Erbitux set for first line treatment of colorectal cancer

June 5, 2008
Sales and Marketing Cancer, Merck Serono

Merck Serono's Erbitux looks set for approval in Europe as a first-line colon cancer treatment. Approved four years ago as …

Data boost for Avastin

June 5, 2008
Sales and Marketing

A new study has confirmed that Roche's Avastin significantly extends time without disease progression for women with metastatic breast cancer. …

Latest news from Datamonitor

June 3, 2008
Sales and Marketing

Drug distribution restricted as manufacturers attempt to guard supply chain Ideally, drug supply should be a simple and transparent chain …

Sanofi fights to block generic Plavix in Germany

June 3, 2008
Sales and Marketing

Sanofi-Aventis is taking legal action to prevent the launch of a generic competitor to its blockbuster Plavix in Germany. At …

Close to home: the UK’s regional NHS influencers

June 3, 2008
Sales and Marketing NICE, UK, healthcare, influencers, regional

With so much attention directed at NICE since the parliamentary health select committee reported on the organisation in January, it …

Roche increases stake in Chugai

May 30, 2008
Sales and Marketing

Roche is strengthening its hold over Japanese drug firm Chugai, increasing its stake in the company from 50.1% to 59.9%. …

A million more patients to get statins

May 30, 2008
Sales and Marketing

Statin prescribing could be set to increase massively once again following new NICE guidance on cholesterol-lowering treatments. An extra 1.5 …

Schering-Plough to exploit new NICE transparency

May 30, 2008
Sales and Marketing

NICE has recommended two anti-TNF treatments for ankylosing spondylitis, the painful and progressive rheumatic disease, but has excluded a third …

BMA rails against polyclinics

May 30, 2008

Doctors have come together to attack plans to introduce polyclinics to London, claiming the reforms are not proven to improve …

Merck’s odanacatib shows promise in cancer

May 30, 2008
Research and Development, Sales and Marketing

Merck's odanacatib (MK-0822) has shown promising results in phase II trials in treating breast cancer which has spread to bones. …

Groundbreaking pharma-NHS collaboration launched in Nottingham

May 30, 2008
ABPI, ABPI Outreach Programme, AstraZeneca, Boehringer Ingelheim, COPD, GlaxoSmithKline, INFORCE, Nottingham, Nycomed, Pfizer, joint working

A group of pharmaceutical companies have joined forces with Nottingham healthcare services to help improve care for patients with chronic …

7 principles in marketing to the new NHS

May 28, 2008
Sales and Marketing NHS, healthcare, marketing

Developing a successful market access strategy has become the Holy Grail for brand teams across the UK pharmaceutical industry.

Latest news from Datamonitor

May 28, 2008
Sales and Marketing em, hc

Potential lung cancer epidemic looming in AsiaLung cancer is the leading cause of cancer-related mortality throughout much of the industrialized …

Lilly unveils streamlined business structure

May 22, 2008
Sales and Marketing lilly, restructure

A simplified and slimmed-down corporate structure has been unveiled by US pharmaceutical firm Lilly, which says it hopes to cut …

Cervical cancer awareness campaign launched

May 22, 2008
Medical Communications

PR agency Consolidated has been hired to help publicise the forthcoming NHS cervical cancer immunisation programme. The Department of Health …

MPs back hybrid embryo research

May 22, 2008

Research using 'hybrid' human/animal embryos has been given the green light by MPs. Politicians, including the Labour and Conservative leaders, …

Gardasil or Cervarix? Government decision imminent

May 22, 2008

A decision on which of the two vaccines for cervical cancer will be used in the nationwide immunisation campaign is …

The Gateway to Local Adoption Series

Latest content